Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSB2200024	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products	Supplementary Application	2022-03-11					view
JYSB1900267	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products	Supplementary Application	2019-09-18			In Review	2019-09-17	view
JXSL2200110	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2022-07-07					view
JXSS1800025	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products	Import Drug Application	2018-10-22	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.	Merck Sharp & Dohme Corp	Certificate Issued	2019-11-28	view
JYSB2400009	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products	Supplementary Application	2024-01-18					view
JXSL2101029	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2021-05-21					view
JXSL2000152	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2020-09-14	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd	In Review	2020-09-11	view
JYSB2100036	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products	Supplementary Application	2021-01-28	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd	In Review	2021-01-27	view
JXSB2101046	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products(3.1)	Supplementary Application	2021-08-17					view
JYSB2000014	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products	Supplementary Application	2020-01-23			In Review	2020-01-22	view
JXSB2200039	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2022-03-28					view
JXSL1900012	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products	Import Drug Application	2019-02-18	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd	In Review	2019-02-15	view
JXSS2400034	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products(3.1)	Import Drug Application	2024-04-04					view
JXSB2101029	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products	Supplementary Application	2021-06-29					view
JXSB2000037	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products	Supplementary Application	2020-11-23	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd	In Review	2020-11-21	view
JXSB2300106	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products	Supplementary Application	2023-08-30					view
JXSB2200052	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products	Supplementary Application	2022-05-05					view
JXSB2300015	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2023-01-17					view
JXSL2000034	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products	Import Drug Application	2020-04-13	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd	In Review	2020-04-11	view
JXSL2200077	帕博利珠单抗注射液	Pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2022-06-10					view